Cargando…
Safety and Efficacy of Nitazoxanide-Based Regimen for the Eradication of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis
BACKGROUND: Helicobacter pylori (HP) is the most common cause of gastritis worldwide. Clarithromycin-based triple therapy or bismuth-based quadruple therapy is usually considered the first-line treatment, however with around 30% failure rate for both regimens. Drug resistance of clarithromycin and m...
Autores principales: | Iqbal, Umair, Khara, Harshit S., Akhtar, Daud, Hu, Yirui, Anwar, Hafsa, Haq, Khwaja F., Siddiqui, Hafiz U., Bergenstock, Marika K., Shellenberger, Matthew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781276/ https://www.ncbi.nlm.nih.gov/pubmed/33447305 http://dx.doi.org/10.14740/gr1342 |
Ejemplares similares
-
Hybrid Therapy Regimen for Helicobacter Pylori Eradication
por: Song, Zhi-Qiang, et al.
Publicado: (2016) -
Adding diclofenac to Helicobacter pylori eradication regimen
por: Emami, Mohammad Hasan, et al.
Publicado: (2015) -
A Randomized Study Comparing Levofloxacin, Omeprazole, Nitazoxanide, and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pylori
por: Basu, P Patrick, et al.
Publicado: (2011) -
Nitazoxanide Use as Part of an Empiric Multi-Drug Regimen in Treating Children with Suspected Helicobacter pylori Infection
por: Ramos-Soriano, Asuncion G., et al.
Publicado: (2014) -
Acute Gastrointestinal Bleeding in COVID-19 Patients: A Systematic Review and Meta-Analysis
por: Iqbal, Umair, et al.
Publicado: (2021)